Company intelligence
LEVICEPT LTD
Biotechnology Research
11 employees
Founded 2012
3 public signals
About LEVICEPT LTD
Levicept Ltd is a UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. LEVI-04 is currently in a phase II study in patients with osteoarthritis of the knee.
Verified activity
Signals from LEVICEPT LTD
3 published signals
People
LEVICEPT LTD employee Tash achieved all the goals for the job start.
Reported by Claire Herholdt
Presence & Recognition
LEVICEPT LTD was invited to attend the Cantor Global Healthcare Conference 2026 in New York from September 9 to 11 at the Waldorf Astoria New York venue.
Reported by LEVICEPT LTD
Research & Knowledge
LEVICEPT LTD founder and CSO Simon Westbrook explained that LEVI-04's ability to target symptoms and potentially modify the disease could unlock a mega-blockbuster for osteoarthritis in an interview with Kevin Grogan of Citeline's EULAR
Reported by LEVICEPT LTD